Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
J Mol Cell Cardiol ; 91: 160-71, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26779948

ABSTRACT

Large studies in humans and animals have demonstrated a clear association of an adverse intrauterine environment with an increased risk of cardiovascular disease later in life. Yet mechanisms remain largely elusive. The present study tested the hypothesis that gestational hypoxia leads to promoter hypermethylation and epigenetic repression of the glucocorticoid receptor (GR) gene in the developing heart, resulting in increased heart susceptibility to ischemia and reperfusion injury in offspring. Hypoxic treatment of pregnant rats from day 15 to 21 of gestation resulted in a significant decrease of GR exon 14, 15, 16, and 17 transcripts, leading to down-regulation of GR mRNA and protein in the fetal heart. Functional cAMP-response elements (CREs) at -4408 and -3896 and Sp1 binding sites at -3425 and -3034 were identified at GR untranslated exon 1 promoters. Hypoxia significantly increased CpG methylation at the CREs and Sp1 binding sites and decreased transcription factor binding to GR exon 1 promoter, accounting for the repression of the GR gene in the developing heart. Of importance, treatment of newborn pups with 5-aza-2'-deoxycytidine reversed hypoxia-induced promoter methylation, restored GR expression and prevented hypoxia-mediated increase in ischemia and reperfusion injury of the heart in offspring. The findings demonstrate a novel mechanism of epigenetic repression of the GR gene in fetal stress-mediated programming of ischemic-sensitive phenotype in the heart.


Subject(s)
Epigenesis, Genetic , Hypoxia/genetics , Myocardial Reperfusion Injury/genetics , Oxygen/pharmacology , Receptors, Glucocorticoid/genetics , Sp1 Transcription Factor/genetics , Animals , Animals, Newborn , Azacitidine/analogs & derivatives , Azacitidine/pharmacology , Binding Sites , DNA Methylation/drug effects , Decitabine , Exons , Female , Hypoxia/drug therapy , Hypoxia/metabolism , Hypoxia/pathology , Male , Maternal Exposure , Myocardial Reperfusion Injury/metabolism , Myocardial Reperfusion Injury/pathology , Myocardial Reperfusion Injury/prevention & control , Phenotype , Pregnancy , Promoter Regions, Genetic , Protein Binding , Rats , Rats, Sprague-Dawley , Receptors, Glucocorticoid/antagonists & inhibitors , Receptors, Glucocorticoid/metabolism , Response Elements , Sp1 Transcription Factor/metabolism
3.
Comp Immunol Microbiol Infect Dis ; 73: 101562, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33091862

ABSTRACT

Avian Influenza (AI), caused by Alphainfluenzaviruses (AIVs), is a contagious respiratory disease in birds and mammals. AIVs have been reported in poultry worldwide and the impact of AIVs on human health is immense. In this study, a serological survey of AIV subtype H5 and H9 was conducted in a live bird market (LBM) in Yangon, Myanmar during February 2016 to September 2016. A total of 621 serum samples were collected from chickens (n = 489) and ducks (n = 132) from 48 vendors in the LBM. The samples were examined for antibodies against influenza viruses by using NP-ELISA and specific antibodies against AIV-H5N1 (Clade 2.3.4) and AIV-H9N2 (Clade 9.4.2) by using Hemagglutination Inhibition (HI) assay. The result of NP-ELISA assay showed that 12.88 % (80/621) of poultry in LBM was positive for AIV antibodies. In detail, 38.06 % (51/134) of layers, 7.08 % (8/113) of backyard chicken, 2.07 % (5/242) of broilers and 12.12 % (16/132) of ducks were AIV positive. The HI test for specific antibodies against AIV-H5N1 and AIV-H9N2 were 1.77 % (11/621) and 4.51 % (28/621), respectively. Our findings revealed the evidence of AIV-H5N1 and AIV-H9N2 exposure in both chicken and ducks in the LBM in Yangon, Myanmar. Risks of influenza infections and transmission among poultry and humans in the LBMs could not be ignored.


Subject(s)
Chickens , Ducks , Influenza A Virus, H5N1 Subtype/immunology , Influenza A Virus, H9N2 Subtype/immunology , Influenza in Birds/virology , Animals , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Hemagglutination Inhibition Tests/veterinary , Influenza in Birds/epidemiology , Male , Myanmar/epidemiology
4.
Food Sci Nutr ; 7(3): 1063-1071, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30918649

ABSTRACT

To investigate the bacterial content and risk factors associated with the hygienic quality of raw milk, a cross-sectional study was conducted in four townships of Mandalay Region, Myanmar. From April to October 2017, bulk tank milk samples (n = 233) were collected from 233 dairy cattle farms located in Tada-U, Pyin Oo Lwin, Meiktila, and Patheingyi Townships. From each farm, approximately 100 ml of bulk tank milk was collected and examined for bacterial content. Total bacterial count (TBC) and coliform count (CC) in milk samples were determined using milk agar and violet red bile agar. Of 233 milk samples, 68.2% (159/233) showed TBC higher than 1.0 × 105 cfu/ml, and 78.4% (183/233) showed CC higher than 100 cfu/ml. The mean value of TBC among 233 farms was 2.55 × 107 cfu/ml, ranging from 6.0 × 103 to 3.0 × 109 cfu/ml, whereas the mean value of CC was 1.59 × 105 cfu/ml, ranging from 10 to 8.4 × 106 cfu/ml. TBC tended to increase as CC increased in milk samples. The number of precautionary measures for milking operation, choice of cleaning materials, training experience of the farmers, cleanliness score of milking cows, and CMT scores of milk were significantly associated (p < 0.05) with TBC in bulk tank milk. Similarly, the number of precautionary measures for milking operation, choice of cleaning materials, training experience of the farmers, cleanliness scores of milking cows, CMT scores of milk samples, herd size, and type of milking practice showed significant association (p < 0.05) with CC in bulk tank milk. The effects of these potential risk factors should be minimized, farmers should be trained properly, and technical support should be provided, so that the quality of raw milk produced in Myanmar can be improved.

5.
PLoS One ; 10(4): e0125033, 2015.
Article in English | MEDLINE | ID: mdl-25923220

ABSTRACT

The potential adverse effect of synthetic glucocorticoid, dexamethasone therapy on the developing heart remains unknown. The present study investigated the effects of dexamethasone on cardiomyocyte proliferation and binucleation in the developing heart of newborn rats and evaluated DNA methylation as a potential mechanism. Dexamethasone was administered intraperitoneally in a three day tapered dose on postnatal day 1 (P1), 2 and 3 to rat pups in the absence or presence of a glucocorticoid receptor antagonist Ru486, given 30 minutes prior to dexamethasone. Cardiomyocytes from P4, P7 or P14 animals were analyzed for proliferation, binucleation and cell number. Dexamethasone treatment significantly increased the percentage of binucleated cardiomyocytes in the hearts of P4 pups, decreased myocyte proliferation in P4 and P7 pups, reduced cardiomyocyte number and increased the heart to body weight ratio in P14 pups. Ru486 abrogated the effects of dexamethasone. In addition, 5-aza-2'-deoxycytidine (5-AZA) blocked the effects of dexamethasone on binucleation in P4 animals and proliferation at P7, leading to recovered cardiomyocyte number in P14 hearts. 5-AZA alone promoted cardiomyocyte proliferation at P7 and resulted in a higher number of cardiomyocytes in P14 hearts. Dexamethasone significantly decreased cyclin D2, but not p27 expression in P4 hearts. 5-AZA inhibited global DNA methylation and blocked dexamethasone-mediated down-regulation of cyclin D2 in the heart of P4 pups. The findings suggest that dexamethasone acting on glucocorticoid receptors inhibits proliferation and stimulates premature terminal differentiation of cardiomyocytes in the developing heart via increased DNA methylation in a gene specific manner.


Subject(s)
Dexamethasone/administration & dosage , Epigenesis, Genetic , Heart/growth & development , Myocytes, Cardiac/pathology , Receptors, Glucocorticoid/biosynthesis , Animals , Animals, Newborn , Cell Proliferation/drug effects , Cyclin D2/biosynthesis , Cyclin-Dependent Kinase Inhibitor p27/biosynthesis , DNA Methylation/drug effects , Gene Expression Regulation, Developmental/drug effects , Heart/drug effects , Humans , Mifepristone/administration & dosage , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Rats
6.
Pediatr Rep ; 4(1): e5, 2012 Jan 02.
Article in English | MEDLINE | ID: mdl-22690311

ABSTRACT

Community-acquired methicillin-resistant Staphylococcus aureus has become a well-established pathogen with alarming rates during the last decade. The current situation of this bacteria in pediatric infections is very limited and motivated us to conduct this study. This is a retrospective and analytical study including patients less than 18 years of age with the diagnosis of skin or soft tissue infections in 2008 and 2009 meeting the criteria of Community-acquired infection. A prevalence of 41.9% among skin and soft tissue infections was found. Inducible resistance to clindamycin was detected in 1.3% of the strains and the infection shows a seasonal predilection for summer (P=0.003); 57.8% of the cases required hospitalization with a mean stay of 3.3±2.5 days. The susceptibility to clindamycin and co-trimoxazole is 88 and 97% respectively. The resistance to erythromycin has reached 92%. The main diagnoses at presentation was gluteal abscess plus cellulitis (34.2%).The prevalence of CA-MRSA is trending up and seems to become a large burden for the health system in our community. Clindamycin is still an excellent option in the community setting since inducible clindamycin resistance is extremely low in this community. Co-trimoxazole should be kept as a reserved drug to avoid the rapid resurgence resistance in the community.

SELECTION OF CITATIONS
SEARCH DETAIL